tenXclinical
tenXclinical is a strategic AI partner focused on enhancing enterprise clinical trial operations. Their key product, Ally, is a secure AI platform custom-trained on client procedures, aimed at streamlining workflows for clinical research teams and participants globally. With a mission to shorten drug development timelines, tenXclinical leverages expertise from industry leaders to provide value-added AI resources, making clinical research more accessible and efficient. Their differentiation lies in their deep understanding of clinical operations and technology, positioning them as a trusted partner in the clinical trial landscape.
tenXclinical
tenXclinical is a strategic AI partner focused on enhancing enterprise clinical trial operations. Their key product, Ally, is a secure AI platform custom-trained on client procedures, aimed at streamlining workflows for clinical research teams and participants globally. With a mission to shorten drug development timelines, tenXclinical leverages expertise from industry leaders to provide value-added AI resources, making clinical research more accessible and efficient. Their differentiation lies in their deep understanding of clinical operations and technology, positioning them as a trusted partner in the clinical trial landscape.
TL;DR
What they do: AI-enabled platform and services to streamline enterprise clinical trial operations
Headline product: Ally — secure AI platform custom-trained on client procedures
Headquarters: Princeton, New Jersey
Stage / funding: Early-stage; reported $50k seed (Jul 2023)
Team size: ~3 employees (public profile)
Company Overview
Problem Domain
Clinical trial operations inefficiencies and workflow complexity in enterprise research settings.
Industry
Enterprise clinical trial software / health AI
Funding Track Record
$50,000
Dealroom lists a Jul 2023 seed entry of $50.0k; other public profiles show obfuscated funding details
Investor Signal
“Buffalo Innovation Seed Fund”